Ozempic Face or Ozempic Butt: These terms refer to changes in facial and body appearance due to significant weight loss, often leading to sagging skin or a deflated look
[26] In 2015, the US Food and Drug Administration (FDA) added a new warning and precaution about the risk of "severe and disabling" joint pain to the labels of all DPP-4 inhibitor medicines
For most patients, feeling colder whilst taking GLP-1 medications is commonly reported and often related to weight loss rather than a direct drug adverse effect
Inject the missed dose as soon as you remember it
Neither has tirzepatide (Mounjaro, Zepbound), another blockbuster injectable medication in the same family
This process continues for the next 17 weeks until the maximum dose, 2.4 mg, is reached